Mr. Culverwell concentrates his practice on patent portfolio development, patent litigation, and IP licensing. Mr. Culverwell has prepared and prosecuted applications in the areas of biotechnology, molecular biology, cell biology, cancer treatment, medical diagnostics, personalized medicine, nucleic acid assays, enzyme replacement therapy, protein pharmaceuticals, medical devices, green technologies, software, and manufactured articles.
Mr. Culverwell also advises clients on various patent-related matters such as freedom-to-operate, patentability, invalidity, and non-infringement analyses, as well as transactional due diligence and IP licensing.
In addition, his practice includes patent litigation and patent litigation support in a variety of fields, such as telecommunications, mobile media, computers, cell biology, and biotechnology.